What is BioHarvest Sciences?
BioHarvest Sciences operates at the intersection of synthetic biology and industrial manufacturing, leveraging a sophisticated plant cell technology platform. This proprietary methodology allows for the large-scale production of complex plant metabolites without the need for traditional agricultural cultivation. By bypassing conventional farming constraints, the company provides a reliable, sustainable, and high-purity supply chain for industries ranging from nutraceuticals to pharmaceuticals. Their platform represents a paradigm shift in how bioactive compounds are synthesized, offering a scalable solution to meet the increasing demand for standardized, high-quality botanical ingredients in a controlled, laboratory-based environment.
How much funding has BioHarvest Sciences raised?
BioHarvest Sciences has raised a total of $796K across 2 funding rounds:
Private Equity
$402K
Other Financing Round
$394K
Private Equity (2025): $402K, investors not publicly disclosed
Other Financing Round (2025): $394K, investors not publicly disclosed
Key Investors in BioHarvest Sciences
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for BioHarvest Sciences?
With the recent influx of capital, BioHarvest Sciences is poised to transition into a phase of aggressive operational scaling and commercial expansion. The strategic roadmap likely involves optimizing its bioreactor infrastructure to increase throughput and reduce unit costs, thereby enhancing its competitive edge in the global supply chain. Furthermore, the company is expected to leverage this financial runway to pursue new partnerships and regulatory approvals, facilitating the integration of its plant-based metabolites into a broader array of consumer and medical products. As the firm matures, the focus will shift toward long-term sustainability and the diversification of its product portfolio, ensuring that its industrial-scale platform remains at the forefront of the bio-manufacturing revolution.
See full BioHarvest Sciences company page
